Lifevantage (LFVN) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Lifevantage Corp  (NASDAQ: LFVN)
 

Lifevantage Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LFVN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) -23.02 % 12.24 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) -2.68 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) -20.52 % 9.25 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) -6.54 % 2.69 % 2.09 % 2.61 %
Revenue 5 Year Average Growth -3.68 % 7.41 % 8.65 % 10.59 %


LFVN's Growth Comparisons in IV. Quarter 2026




Lifevantage's sharp decrease of -23.02% in sales in the fourth quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Major Pharmaceutical Preparations industry with 12.24%, and underperformed the 9.19% Revenue growth in the Healthcare sector. Comparing the fourth quarter, sales Lifevantage Corp was trailing overall market not just Major Pharmaceutical Preparations industry.

Top-line fell by -2.68% from the third quarter. Average annual sales growth for Lifevantage is -3.68%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the fourth quarter 2026 financial results.

LFVN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Reportable Segment
-
317.66 %
US
-
-
JP
-
-
Other Foreign
-
-
Non Us
-
-
Protandim
-
-
True Science Product Line
-
-
United States
-
-0.66 %
AXIO product line
-
337.24 %
TrueScience product line
-
2.56 %
Petandim product line
-
320.82 %
Product and Service Other
-
-
Phys IQ Product Line
-
-
Total
-81.39 %
-2.68 %


Growth Rates of LFVN's Income in the fourth quarter 2026


LFVN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) -22.39 % -8.69 % 5.13 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) -0.66 % -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) -50 % 30.72 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) -7.31 % -2.28 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change -19.11 % 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) -34.71 % -34.78 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -6.09 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -48.27 % 6.22 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -11.82 % -10.03 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change -17.02 % -0.55 % 0.17 % -28.52 %

LFVN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -34.71 % -35.13 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) -6.09 % 2.8 % -0.86 % 27.07 %
Y / Y Net Income Change (Q2 TTM) -48.27 % 5.2 % 15.48 % 57.33 %
Sequential Net Income Change (Q2 TTM) -11.82 % -10.18 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth -17.02 % 14.55 % 9.21 % 22.96 %

LFVN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) -37.5 % -40.16 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -9.09 % -7.73 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -50 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -13.04 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth -15.34 % -10.83 % 0.17 % -28.52 %



LFVN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) -33.84 % -40.49 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) -9.09 % -2.61 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -11.34 % -7.05 % -4.12 % 4.93 %
EPS Net 5 Year Avg. Change -14.97 % 14.55 % 9.21 % 22.96 %



Lifevantage's EPS went down by -33.84% from the same quarter a year ago, in the fourth quarter, to $ 0.10, and Major Pharmaceutical Preparations industry with -40.49% but underperformed the -26.29% EPS slide in the Healthcare sector. Slow fourth quarter 2026 income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were portrayed in Lifevantage Corp results which underperformed overall market.

the bottom-line fell by -9.09% from the third quarter. Average annual income per share growth for Lifevantage is -14.97%, while S & P 500's average yearly income per share increase is 22.96%, including only Businesses with the fourth quarter 2026 earnings.

LFVN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 260.74 % 25.53 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) -6.21 % -42.35 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) -35.59 % 12.28 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 61.09 % 3.34 % 5.76 % 15.75 %
Free Cash Flow 5 Year Avg. Change -11.86 % 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 421.11 % 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 2.57 % -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 160.47 % 16.46 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 30.66 % 2.81 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change -0.93 % 7.84 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.